Advertisement

Topics

CiteAb Names Cell Signaling Technology Antibody Company of the Year

08:00 EST 15 Feb 2018 | PR Web

Antibody Company of the Year” and “Antibody Company Succeeding in Cancer Biology"

DANVERS, Mass. (PRWEB) February 15, 2018

Cell Signaling Technology. Inc. (CST), a leading provider of antibodies, kits, and services, is honored with the 2018 CiteAb Award for “Antibody Company of the Year” and “Antibody Company Succeeding in Cancer Biology.” CST was also highly commended for the “Chemical Probes Supplier to Watch” and “Antibody Company with Sustained Success in China.” The CiteAb Antibody Awards aim to celebrate the very best suppliers, reagents, and individuals in the research antibody sector, recognizing the efforts that are made to progress science.

Dr. Andrew Chalmers, Founder of CiteAb, said: “This is an esteemed award that recognizes CST as the most successful antibody company based on our data from CiteAb. This is no small feat and a direct result of the company offering a large number of products that help researchers make novel findings. This would not have been possible without a huge amount of effort from everybody at CST. We wholeheartedly congratulate CST on their achievements.”

“Being scientists ourselves, we are truly passionate about scientific discovery. We are honored to be recognized as Antibody Company of the year for having the most antibody life science research citations during 2017. Equally as gratifying is the way in which our antibody products are enabling cancer researchers, as the company having the most citations achieved in the cancer biology research field in 2017. All of us at CST are driven to support researchers, so they can discover faster and more frequently to enable a better future for healthcare,” said Michael J. Comb, Cell Signaling Technology President and CEO.

About CiteAb
CiteAb is the largest citation-ranked antibody search engine and database. It provides an impartial way to find and compare antibodies that work. CiteAb is proud to power product citations on the Cell Signaling Technology website.

Contact: Katrina Kelly
CiteAb Marketing Manager
Phone: 07403 668718
email: kkatrina(at)citeab.co.uk

About CST
Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing high quality research tools to the biomedical research community. Our employees operate worldwide from our U.S. headquarters in Massachusetts, and our offices in the Netherlands, China, and Japan.

Cell Signaling Technology®, and CST™ are trademarks of Cell Signaling Technology, Inc.

CST Media and Press
Rebecca J. Reppucci, MBA
Cell Signaling Technology, Inc.
Director of Marketing Communications
Phone: 978-867-2382
email: marketingpr(at)cellsignal.com

For the original version on PRWeb visit: http://www.prweb.com/releases/2018/02/prweb15157242.htm

NEXT ARTICLE

More From BioPortfolio on "CiteAb Names Cell Signaling Technology Antibody Company of the Year"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...